Bone Diseases, Metabolic Enrolling by Invitation Phase 4 Trials for Calcium carbonate (DB06724)

Also known as: Bone Disease, Metabolic

IndicationStatusPhase
DBCOND0028429 (Bone Diseases, Metabolic)Enrolling by Invitation4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02237534Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and HyperphosphatemiaTreatment